Salivary gland cancer doesn’t grow at a single predictable rate. It varies dramatically by subtype, from tumors that double in size over nearly three years to aggressive forms that spread to distant organs within months of diagnosis. Understanding which type you’re dealing with is the most important factor in predicting how quickly the disease will progress.
Growth Speed Depends on the Subtype
There are more than 20 recognized types of salivary gland cancer, and they fall broadly into low-grade and high-grade categories. Low-grade tumors have uniform, bland-looking cells and tend to grow slowly over months or years. High-grade tumors show signs of rapid cell division, tissue death within the tumor, and abnormal cell structures. These features translate directly into how fast the cancer enlarges and how soon it may spread.
One of the most well-studied slow-growing types is adenoid cystic carcinoma (ACC). Researchers measuring the doubling time of ACC lung metastases found it ranged from 86 to 1,064 days, with an average of 393 days, or just over a year to double in size. That’s considerably slower than most other cancers. But “slow” is misleading here: ACC is persistent, with high rates of both local and distant spread over time. It just takes a longer path to get there.
On the opposite end, salivary duct carcinoma (SDC) is characterized by local aggressiveness and rapid progression. It often presents at an advanced stage because it grows and invades surrounding tissue quickly before patients seek evaluation. A painless lump can become a fixed, nerve-involving mass in a relatively short window.
How Quickly Different Types Spread
Distant metastasis, where cancer cells travel to the lungs, bones, liver, or brain, is one of the clearest measures of how aggressive a salivary gland cancer behaves. Across all subtypes, the median time from completing primary treatment to discovering distant spread is about 20 months. But the range is enormous, from as little as one month to over 16 years later.
The fastest-spreading subtypes tell a stark story. Patients with carcinoma ex pleomorphic adenoma (a cancer that arises within a previously benign tumor) had a median time to distant metastasis of just 9 months. Salivary duct carcinoma followed closely at 12 months. These patients are at risk of early spread and typically need close monitoring during the first two years after surgery.
Slower subtypes take considerably longer. Adenoid cystic carcinoma had a median time to distant metastasis of 33 months, and myoepithelial carcinoma averaged 27 months. Even so, ACC can recur or spread many years after initial treatment, sometimes more than a decade later.
The lungs are the most common destination for metastatic salivary gland cancer, accounting for 63% of distant spread. Bone is second at 31%, followed by the liver at 14% and the brain at 7%. Bone metastases carry a worse prognosis: patients with bone involvement are roughly twice as likely to die from their disease compared to those with lung-only spread.
Recurrence Timelines After Treatment
About one in five patients with salivary gland cancer develops recurrent disease after initial treatment. The average time to recurrence is 38 months, or just over three years. But this average hides important variation. SDC and mucoepidermoid carcinoma tend to recur faster, averaging 26 and 28 months respectively. ACC and adenocarcinoma take longer, averaging 44 and 57 months.
Distant recurrence generally appears sooner than local recurrence. Cancers that come back near the original site do so after an average of about 46 months, while distant metastases are detected after an average of 34 months. Nearly 19% of patients who recur don’t discover it until more than five years after their original diagnosis, which is why long-term follow-up matters for salivary gland cancers in a way it doesn’t for many other tumor types.
When a Low-Grade Tumor Becomes High-Grade
One of the more concerning developments in salivary gland cancer is something called high-grade transformation. A tumor that initially behaves as low-grade, growing slowly with minimal spread, can acquire new genetic changes that make it behave aggressively. When pathologists identify poorly differentiated or high-grade components within an otherwise low-grade cancer, the prognosis shifts significantly. These transformed tumors grow faster, are more likely to metastasize, and require more aggressive treatment. This is one reason biopsy and careful pathologic review matter so much: a tumor’s current grade determines the expected pace of disease far more than its original diagnosis.
Signs That Suggest Faster Growth
Certain clinical features signal that a salivary gland tumor is growing aggressively rather than slowly. A mass that enlarges noticeably over weeks rather than months is concerning. Facial nerve involvement, which can cause weakness or paralysis on one side of the face, strongly suggests malignancy and typically indicates a tumor that has invaded beyond its original boundaries. Pain is another red flag, since most benign salivary tumors are painless. On imaging, tumors with indistinct or irregular borders are more suspicious for malignancy than well-defined masses.
Many patients first notice a firm, painless lump near the jaw or under the tongue that seems to stay the same size for a while before suddenly growing. That shift in behavior can reflect either the natural progression of a high-grade cancer reaching a critical mass or the high-grade transformation of a previously indolent tumor. Either way, a change in growth speed warrants prompt evaluation.